This announcement is a separate document:
ネクセラファーマ:Nxera Pharmaは、提携統合失調症候補者のポジティブなフェーズ2データに注目しています。NBI-1117568
Nxera Pharma: Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.